NCT07656558Not yet recruiting
ACT-Based Psychoeducation for Caregivers of Patients With Schizophrenia
The Effect of Acceptance and Commitment Therapy-Based Psychoeducation Applied to Caregivers of Schizophrenia Patients Attending the Community Mental Health Center on Emotional Expression, Perceived Family Burden, and Psychological Flexibility: A Randomized Controlled Trial
Source: ClinicalTrials.gov · Last updated 18 Jun 2026
Brief summary (registry, in English)
This randomized controlled trial aims to examine the effects of an Acceptance and Commitment Therapy (ACT)-based psychoeducation program on expressed emotion, perceived family burden, and psychological flexibility among caregivers of patients with schizophrenia attending a Community Mental Health Center. The main questions this study aims to answer are: * Does ACT-based psychoeducation reduce expressed emotion among caregivers of patients with schizophrenia? * Does ACT-based psychoeducation reduce perceived family burden among caregivers of patients with schizophrenia? * Does ACT-based psychoeducation improve psychological flexibility among caregivers of patients with schizophrenia? Researchers will randomly assign eligible caregivers to either an intervention group receiving an 8-session ACT-based psychoeducation program or a control group receiving routine care. Participants will: * Complete assessment measures before the intervention (pre-test). * Participate in 8 ACT-based psychoeducation sessions if assigned to the intervention group. * Continue receiving routine care if assigned to the control group. * Complete assessment measures immediately after the intervention (post-test). * Complete follow-up assessments at 1 month and 3 months after the intervention.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 14 Jun 2026
- Start date
- 1 Jul 2026
- Primary completion date
- 30 Dec 2026
- Lead sponsor
- Aydin Adnan Menderes University
- Diseases
- Schizophrenia
- NCT number
- NCT07656558
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Jul 2026 to the primary completion date, 30 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Having a medically diagnosed psychiatric disorder.
- Having a diagnosis of an organic mental disorder or intellectual disability.
- Having a physical impairment that may interfere with participation in the study or data collection process (e.g., hearing or speech impairment).
Who the study is looking for
- Living with an individual diagnosed with schizophrenia who has been followed and actively receiving services from a Community Mental Health Center for at least one year.
- Being the primary caregiver responsible for the care of the individual diagnosed with schizophrenia.
- Having been involved in the care and treatment of the individual diagnosed with schizophrenia for at least 12 months prior to the study.
- Being between 18 and 65 years of age.
- Being literate.
- Being able to speak and understand Turkish.
- Willing to participate in the study and providing informed consent.
Age in the registry: 18 years to 65 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Nevşehir State Hospital Community Mental Health Center Coordinator of this site? Confirm its status | Nevşehir | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.